Cargando…

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial

OBJECTIVE: This open-label study examined the effects of ramelteon on cognitive functions in 10 outpatients with schizophrenia. METHODS: Ramelteon (8 mg/day) was administered to 10 patients with schizophrenia for six months. The verbal fluency test, Trail-Making Test, the Wisconsin Card Sorting Test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirayama, Yukihiko, Takahashi, Michio, Suzuki, Masatoshi, Tsuruoka, Yoshiaki, Sato, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293167/ https://www.ncbi.nlm.nih.gov/pubmed/25598825 http://dx.doi.org/10.9758/cpn.2014.12.3.215

Ejemplares similares

Utility of the Neurobehavioral Cognitive Status Examination (COGNISTAT) in differentiating between depressive states in late-life depression and late-onset Alzheimer’s disease: a preliminary study
por: Tsuruoka, Yoshiaki, et al.
Publicado: (2016)

Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression
por: Takahashi, Michio, et al.
Publicado: (2013)

A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales
por: Suzuki, Masatoshi, et al.
Publicado: (2014)

Personality Traits as Risk Factors for Treatment-Resistant Depression
por: Takahashi, Michio, et al.
Publicado: (2013)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Add-on Yoga Therapy for Social Cognition in Schizophrenia: A Pilot Study
por: Govindaraj, Ramajayam, et al.
Publicado: (2018)

Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023)

Cognitive behavioral therapy for postpartum panic disorder: a case series
por: Matsumoto, Kazuki, et al.
Publicado: (2019)

Open-label, add-on trial of cetirizine for neuromyelitis optica
por: Katz Sand, Ilana, et al.
Publicado: (2018)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Evaluation of the Anxiolytic Effect of Ramelteon in Various Rat Models of Anxiety
por: Nachiappan, KR, et al.
Publicado: (2023)

Circulating Neuroactive Steroid Levels in a Patient With Schizophrenia Who Showed Periodic Catatonia
por: Muneoka, Katsumasa, et al.
Publicado: (2023)

Associations among autistic traits, cognitive and affective empathy, and personality traits in adults with autism spectrum disorder and no intellectual disability
por: Shirayama, Yukihiko, et al.
Publicado: (2022)

Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report
por: Hou, Yi-Cheng, et al.
Publicado: (2016)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Ramelteon Reduces Oxidative Stress by Maintenance of Lipid Homeostasis in Porcine Oocytes
por: Sun, Jing-Tao, et al.
Publicado: (2022)

Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms
por: Shimizu, Nobutaka, et al.
Publicado: (2013)

The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study
por: Suzuki, Keisuke, et al.
Publicado: (2022)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

Preventative effects of ramelteon against postoperative delirium after elective liver resection
por: Hokuto, Daisuke, et al.
Publicado: (2020)

Add-on effect of Brahmi in the management of schizophrenia
por: Sarkar, Sukanto, et al.
Publicado: (2012)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Premorbid intellectual ability in schizophrenia influence family appraisal related to cognitive impairments: a cross-sectional study on cognitive impairment and family assessments
por: Ebina, Kota, et al.
Publicado: (2022)

The optimal dose of Ramelteon for the better treatment adherence of delayed sleep–wake phase disorder: a dropout rate study
por: Takagi, Shunsuke, et al.
Publicado: (2023)

An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients
por: Carta, Mauro Giovanni, et al.
Publicado: (2006)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial
por: Tsunoda, Tetsuji, et al.
Publicado: (2016)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury
por: Wu, Xiao-li, et al.
Publicado: (2020)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2022)

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
por: Takeshima, Masahiro, et al.
Publicado: (2018)

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study
por: Antczak, Jakub, et al.
Publicado: (2018)

Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia
por: Terevnikov, Viacheslav, et al.
Publicado: (2015)

Attenuation of Morphine Physical Dependence and Blood Levels of Cortisol by Central and Systemic Administration of Ramelteon in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sseik4isdhilgkedtan6q7233f